NASDAQ •
Healthcare •
Drug Manufacturers - General •
Quote as of 09/03/2026 14:11
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeNASDAQ
Market Capitalization232,407 mln
Float540 mln
Earnings Date11/03/2026
EPS
16.12
Robust
P / E
27.50
Elevated
Piotroski F-Score
8
/ 9
Very strong
Beneish M-Score
-2.62
Likely reliable
1-Year Forecast
388
Limited downside
Relative Strength
81
/ 100
Strongly outperforming
Business Description
Founded in 1980 and based in Thousand Oaks, California, Amgen is a global medicine company focused on developing and producing treatments for serious conditions such as cancer, bone disease, heart disease, and autoimmune disorders. The company sells a broad range of products to hospitals, clinics, and pharmacies, reaching patients through wholesale distributors. Amgen also works alongside several partner companies, including AstraZeneca and BeiGene, to expand its research and bring new treatments to market.
